Licensed Vocational Nurse 3 administered hydralazine to Resident 4 on November 8, 2025, at 9 p.m., despite the resident's blood pressure measuring 100/67 mmHg. The physician had explicitly ordered staff to hold the medication when systolic blood pressure dropped below 110 mmHg.
The error occurred at Astoria Healthcare Center during federal inspectors' November investigation. Resident 4 had been living at the facility since May 2013 with multiple serious heart conditions, including unspecified heart failure, atrial fibrillation, and essential hypertension.
Hydralazine hydrochloride is prescribed to lower blood pressure. Giving it to someone whose blood pressure is already too low can cause hypotension, dizziness, and potentially fatal complications.
The physician's order was clear: give one 10-milligram tablet by mouth every 12 hours, but hold the dose if systolic blood pressure falls below 110 mmHg or if heart rate drops below 60 beats per minute.
Resident 4's systolic reading of 100 was a full 10 points below the safety threshold.
During interviews with federal inspectors, facility administrators acknowledged the dangerous mistake. The Director of Staff Development confirmed that LVN 3 should have held the medication because the resident's blood pressure was below 110 mmHg.
"LVN 3 should have followed the physician's order," the Director of Staff Development told inspectors on November 18. The administrator stated that Resident 4 could experience hypotension after receiving the inappropriate dose.
The Director of Nursing was even more direct about the potential consequences. During a separate interview the same day, the nursing director confirmed that LVN 3 should have followed the physician's order to hold the medication.
The nursing director stated that Resident 4 could experience dizziness and hypotension, and the error "could possibly lead to Resident 4's death."
Resident 4's medical history made the medication error particularly concerning. The resident was admitted in 2013 with heart failure, meaning the heart muscle doesn't pump blood as effectively as it should. The resident also had atrial fibrillation, an irregular and often rapid heart rhythm that can complicate blood pressure management.
By 2025, Resident 4's condition had deteriorated significantly. A Minimum Data Set assessment from September 25, 2025, indicated the resident's cognitive skills for daily decisions were severely impaired. This meant Resident 4 likely couldn't advocate for their own safety or question why they were receiving medication when feeling unwell.
The facility's own medication administration policy, dated October 1, 2023, and last reviewed on June 19, 2025, states that medication will be administered by a licensed nurse per the order of an attending physician or licensed independent practitioner.
LVN 3 had access to both the physician's order and the resident's current vital signs when making the decision to administer the medication. The order summary report from June 28, 2025, clearly specified the hold parameters. The medication administration record from November 2025 documented both the blood pressure reading and the medication given.
Federal inspectors found the violation during a complaint investigation at the 120-bed facility. The inspection report indicates this was one of multiple pharmaceutical service failures identified during the review.
The error represents a breakdown in the facility's medication safety systems. Licensed nurses are trained to check physician orders against current patient conditions before administering any medication, particularly those affecting cardiovascular function.
Blood pressure medications like hydralazine require careful monitoring because they can cause dramatic drops in blood pressure, especially in elderly residents with multiple heart conditions. The physician's hold parameters were designed specifically to prevent this type of dangerous outcome.
For residents with heart failure like Resident 4, maintaining adequate blood pressure is critical for organ function. When blood pressure drops too low, vital organs including the brain, kidneys, and heart itself may not receive sufficient blood flow.
The combination of Resident 4's existing heart conditions and severely impaired cognitive function made the medication error particularly dangerous. The resident couldn't communicate symptoms of hypotension such as dizziness, weakness, or confusion that might have alerted staff to the problem.
Astoria Healthcare Center has operated in Sylmar since at least 2013, when Resident 4 was first admitted. The facility provides long-term care and rehabilitation services to elderly residents with complex medical conditions.
The November inspection was conducted in response to complaints about the facility's operations. Federal inspectors reviewed medication administration records, physician orders, and facility policies while interviewing key staff members about pharmaceutical services.
The violation was classified as having minimal harm or potential for actual harm, affecting few residents. However, the Director of Nursing's acknowledgment that the error could have led to death suggests the potential consequences were far more serious than the classification indicates.
Resident 4 remained at the facility as of the November inspection. The inspection report does not indicate whether the resident experienced any immediate adverse effects from receiving the inappropriate medication dose.
The medication error occurred despite the facility having clear policies requiring nurses to follow physician orders. The policy reviewed by inspectors emphasized that licensed nurses must administer medications according to physician or licensed practitioner orders.
LVN 3's decision to override the physician's safety parameters represents a fundamental failure in medication administration protocols that could have had fatal consequences for a vulnerable resident with multiple heart conditions and severe cognitive impairment.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Astoria Healthcare Center from 2025-11-21 including all violations, facility responses, and corrective action plans.